Ambrosia Systems Inc logo

Ambrosia Systems Inc

Revolutionizing Diabetes Care with AI Powered Sensor-Agnostic, Real-Time Glucose and Stress Monitoring Platform

23 employees · est. 2016 · San Francisco, United States

VS
Signos logo

Signos

The world’s first FDA-cleared AI-driven app and CGM for weight management and wellness.

101 employees · est. 2018

Ambrosia Systems Inc is the older company (2016 vs 2018); Signos is the larger of the two.

Side-by-Side Comparison

Ambrosia Systems Inc Signos
Founded
2016 older 2018
Headquarters
San Francisco, United States Not tracked yet
Employees
23 101 larger
Industry
Data Analytics, Health Care, Health and Wellness Health Care, Machine Learning
Funding Stage
Not tracked yet Series B
Total Funding
Not tracked yet $33.00M
Funding Rounds
Not tracked yet 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Continuous Glucose Monitoring, Healthcare Integration, Health Sensors, AI/ML, Fitness, Weight Loss, Diabetes Management, Patient Monitoring, Diabetes Solutions, Remote Monitoring, Digital Health, Innovation FDA-cleared App, AI-driven Technology, Metabolic Health, Continuous Glucose Monitoring, Weight Management, Employer Health Benefits, Personalized Health Recommendations, Predictive Health Analytics, Glucose Stabilization, AI-enhanced Wellness, Sustainable Weight Loss, Health Data Platform, Metabolism Optimization, Healthcare Cost Management, Obesity Prevention
Website
ambrosiasys.com signos.com
Ambrosia Systems Inc logo

About Ambrosia Systems Inc

Ambrosia Systems Inc is a United States-based startup founded in 2016. The company focuses on the health care industry and is committed to "Building Next Generation Real-time CGM." Ambrosia's core offering includes an integrated health data platform that consolidates information from medical devices...

Signos logo

About Signos

Signos, founded in 2018, is pioneering a new frontier in healthcare by providing a unique means to manage weight and metabolic health through an FDA-cleared platform. At the intersection of Health Care and Machine Learning, Signos leverages Dexcom's Stelo CGM technology and advanced AI to convert gl...

We will tell you when either one moves

BounceWatch watches Ambrosia Systems Inc and Signos for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ambrosia Systems Inc and Signos — by email.

Frequently Asked Questions

Ambrosia Systems Inc — Revolutionizing Diabetes Care with AI Powered Sensor-Agnostic, Real-Time Glucose and Stress Monitoring Platform. Signos — The world’s first FDA-cleared AI-driven app and CGM for weight management and wellness. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ambrosia Systems Inc has raised undisclosed funding while Signos has raised $33.00M.
Ambrosia Systems Inc and Signos operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ambrosia Systems Inc with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Ambrosia Systems Inc on 12 Sep 2024, and Signos on 6 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes